Toyobo Co

Toyobo Co Equity

The The Equity of Toyobo Co (3101.T) as of Nov 5, 2026 is 213.31 B JPY. In the previous year, The Equity was 195.31 B JPY — a change of 9.22% (higher).

Equity

213.31 BJPY

YoY

9.22%

Last updated:

In 2026, Toyobo Co's equity was 213.31 B JPY, a 9.22% increase from the 195.31 B JPY equity in the previous year.

The Toyobo Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
176.59 B JPY
Jan 1, 2020
177.89 B JPY
Jan 1, 2021
185.73 B JPY
Jan 1, 2022
194.88 B JPY
Jan 1, 2023
189.59 B JPY
Jan 1, 2024
197.03 B JPY
Jan 1, 2025
195.31 B JPY
Jan 1, 2026
213.31 B JPY
The Toyobo Co Equity history
YEAREquityYoY
213.31 BJPY+9.22%
195.31 BJPY-0.87%
197.03 BJPY+3.93%
189.59 BJPY-2.71%
194.88 BJPY+4.92%
185.73 BJPY+4.41%
177.89 BJPY+0.74%
176.59 BJPY-2.20%
180.56 BJPY+7.62%
167.77 BJPY+6.92%
156.92 BJPY-0.68%
157.99 BJPY+11.02%
142.31 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Toyobo Co Stock analysis

What does Toyobo Co do? Toyobo Co Ltd is a Japanese company that was founded in 1882 as a manufacturer and distributor of silk products. Over the decades, the company has evolved into a multinational corporation focused on high-tech materials and biotechnological applications. Toyobo's business model is centered around the development and production of advanced materials for a variety of applications. This includes specialty fibers, plastics, films, and chemical products. The company is divided into five different business segments: New Materials, Advanced Polymer Products, Life Science, Biomaterials, and Textiles. The New Materials segment focuses on the development and production of high-performance materials for various industries, including automotive, aerospace, electronics, and construction. This includes, for example, aramid fibers, which are used in numerous applications due to their high strength and heat resistance, as well as specialty films that serve as barriers against gases and liquids. Advanced Polymer Products specializes in the development and production of plastic products. The range of offerings includes films, hoses, tapes, profiles, as well as injection-molded parts and components for the automotive industry. In the Life Science segment, the focus is on the manufacturing of diagnostic and test kits, as well as the development of therapies and pharmaceuticals. An example of this is the drug Mirabegron, developed by Toyobo, which is used for the treatment of urinary incontinence. Biomaterials deals with the production of materials for medical applications, including implants and artificial organs. A notable example is the production of the high-performance polymer BioMel by Toyobo, which is known for its durability and biocompatibility. In the Textiles segment, Toyobo manufactures a variety of products made from silk, cotton, and synthetic materials. This includes clothing, bedding, as well as fabrics for interior and automotive applications. Over the years, Toyobo has introduced a wide range of innovative products to the market. Examples include flame-resistant fibers and fabrics used in the aerospace industry, as well as gas barrier films for food and beverages that enable longer shelf life. Overall, Toyobo is a company with an impressive history and a diverse product portfolio. The company aims to tackle the challenges of the future and enable continuous progress in various industries through the development and commercialization of advanced materials and technologies. Toyobo Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Toyobo Co's Equity

Toyobo Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Toyobo Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Toyobo Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Toyobo Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Toyobo Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Toyobo Co stock

The Equity of Toyobo Co is 213.31 B JPY in 2026.

The Equity of Toyobo Co changed from 195.31 B JPY to 213.31 B JPY, representing a 9.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Toyobo Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Toyobo Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Toyobo Co

All Key Metrics — Toyobo Co